The invention provides vitamin K-dependent polypeptides with enhanced membrane binding affinity. These polypeptides can be used to modulate clot formation in mammals. Methods of modulating clot formation in mammals are also described.

 
Web www.patentalert.com

< Agent or method for treating severe aphasia in cerebrovascular accident chronic stage

> Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
~ 00492